We narrowed to 196 results for: AAV9

1. pAAV-CAG-iSeroSnFR-Nlgn (AAV9)

   Viral Prep

   #128485-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-CAG-iSeroSnFR-Nlgn (#128485). In addition to the viral particles, you will also receive purified pAAV-CAG-iSeroSnFR-Nlgn plasmid DNA. CAG-driven expression of a fluorescent reporter for serotonin (localized to dendrites). These AAV preparations are suitable purity for injection into animals.

   Depositor

   Lin Tian

   Article

   Unger et al Cell. 2020 Dec 12. pii: S0092-8674(20)31

   Promoter

   CAG

   Available Since

   Feb. 27, 2024

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-hSynapsin- soCoChR-GFP (AAV9)

   Viral Prep

   #107708-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-hSynapsin- soCoChR-GFP (#107708). In addition to the viral particles, you will also receive purified pAAV-hSynapsin- soCoChR-GFP plasmid DNA. Synapsin-driven somatic CoChR (soCoChR) fused to GFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Shemesh et al Nat Neurosci. 2017 Dec;20(12):1796-1806.

   Promoter

   Syn

   Tags

   GFP

   Available Since

   Sept. 7, 2018

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-hsyn-GRAB_rDA-mut (AAV9)

   Viral Prep

   #140558-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-hsyn-GRAB_rDA-mut (#140558). In addition to the viral particles, you will also receive purified pAAV-hsyn-GRAB_rDA-mut plasmid DNA. Synapsin-driven expression of control red fluorescent dopamine sensor GRAB_rDA-mut (does not respond to DA). These AAV preparations are suitable purity for injection into animals.

   Depositor

   Yulong Li

   Article

   Sun et al Nat Methods. 2020 Nov;17(11):1156-1166.

   Promoter

   Syn

   Available Since

   Aug. 31, 2021

   Availability

   Academic Institutions and Nonprofits only

4. pAAV-CaMKIIa-C1V1 (t/t)-TS-EYFP (AAV9)

   Viral Prep

   #35499-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-CaMKIIa-C1V1 (t/t)-TS-EYFP (#35499). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-C1V1 (t/t)-TS-EYFP plasmid DNA. CaMKIIa-driven, C1V1 (t/t) fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Article

   Yizhar et al Nature. 2011 Jul 27;477(7363):171-8. doi

   Promoter

   CaMKII

   Tags

   EYFP

   Available Since

   April 6, 2018

   Availability

   Academic Institutions and Nonprofits only

5. pAAV.CaMKIIa.ChETA(E123T/H134R)-eYFP.WPRE.hGH (AAV9)

   Viral Prep

   #100050-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV.CaMKIIa.ChETA(E123T/H134R)-eYFP.WPRE.hGH (#100050). In addition to the viral particles, you will also receive purified pAAV.CaMKIIa.ChETA(E123T/H134R)-eYFP.WPRE.hGH plasmid DNA. CaMKIIa-driven, ChETA(E123T/H134R)-eYFP expression for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Promoter

   CaMKII

   Tags

   EYFP

   Available Since

   April 3, 2018

   Availability

   Academic Institutions and Nonprofits only

6. pAAV CD68-hM4D(Gi)-mCherry (AAV9)

   Viral Prep

   #75033-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV CD68-hM4D(Gi)-mCherry (#75033). In addition to the viral particles, you will also receive purified pAAV CD68-hM4D(Gi)-mCherry plasmid DNA. CD68-driven hM4D(Gi) receptor with an mCherry reporter for CNO-induced microglial inhibition. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Bryan Roth

   Article

   Grace et al Proc Natl Acad Sci U S A. 2016 Jun 14;11

   Promoter

   CD68

   Tags

   mCherry

   Available Since

   Sept. 27, 2023

   Availability

   Academic Institutions and Nonprofits only

7. pAAV-S5E2-C1V1-eYFP (AAV9)

   Viral Prep

   #135633-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-S5E2-C1V1-eYFP (#135633). In addition to the viral particles, you will also receive purified pAAV-S5E2-C1V1-eYFP plasmid DNA. Expression of red-shifted opsin C1V1 fused to EYFP under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   EYFP

   Available Since

   Aug. 27, 2021

   Availability

   Academic Institutions and Nonprofits only

8. pAAV.hSynap.ChETA(E123T/H134R)-eYFP.WPRE.hGH (AAV9)

   Viral Prep

   #100049-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV.hSynap.ChETA(E123T/H134R)-eYFP.WPRE.hGH (#100049). In addition to the viral particles, you will also receive purified pAAV.hSynap.ChETA(E123T/H134R)-eYFP.WPRE.hGH plasmid DNA. Synapsin-driven ChETA(E123T/H134R)-EYFP expression for optogenetic neural activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Promoter

   Syn

   Tags

   EYFP

   Available Since

   Feb. 21, 2018

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-CAG-NIR-GECO2G (AAV9)

   Viral Prep

   #159605-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-CAG-NIR-GECO2G (#159605). In addition to the viral particles, you will also receive purified pAAV-CAG-NIR-GECO2G plasmid DNA. CAG-driven expression of the near-infrared calcium indicator NIR-GECO2G. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Robert Campbell

   Article

   Qian et al PLoS Biol. 2020 Nov 24;18(11):e3000965.

   Promoter

   CAG

   Available Since

   Dec. 18, 2024

   Availability

   Academic Institutions and Nonprofits only

10. pAAV-synapsin-HaloCaMP1a-EGFP (AAV9)

    Viral Prep

    #138327-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-synapsin-HaloCaMP1a-EGFP (#138327). In addition to the viral particles, you will also receive purified pAAV-synapsin-HaloCaMP1a-EGFP plasmid DNA. Synapsin-driven HaloCaMP1a, a far-red calcium sensor, fused to EGFP. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Eric Schreiter

    Article

    Deo et al Nat Chem Biol. 2021 Jun;17(6):718-723. d

    Promoter

    Syn

    Tags

    EGFP

    Available Since

    Sept. 15, 2021

    Availability

    Academic Institutions and Nonprofits only

11. pAAV-synapsin-HaloCaMP1b-EGFP (AAV9)

    Viral Prep

    #138328-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-synapsin-HaloCaMP1b-EGFP (#138328). In addition to the viral particles, you will also receive purified pAAV-synapsin-HaloCaMP1b-EGFP plasmid DNA. Synapsin-driven HaloCaMP1b, a far-red calcium sensor, fused to EGFP. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Eric Schreiter

    Article

    Deo et al Nat Chem Biol. 2021 Jun;17(6):718-723. d

    Promoter

    Syn

    Tags

    EGFP

    Available Since

    Sept. 15, 2021

    Availability

    Academic Institutions and Nonprofits only

12. pAAV-CAG-FLEx-iSeroSnFR (AAV9)

    Viral Prep

    #128486-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-CAG-FLEx-iSeroSnFR (#128486). In addition to the viral particles, you will also receive purified pAAV-CAG-FLEx-iSeroSnFR plasmid DNA. CAG driven, Cre-dependent expression of iSeroSnFR. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Lin Tian

    Article

    Unger et al Cell. 2020 Dec 12. pii: S0092-8674(20)31

    Promoter

    CAG

    Available Since

    Sept. 27, 2024

    Availability

    Academic Institutions and Nonprofits only

13. pAAV-hSyn-DIO-hM4D(Gi)-mCherry (AAV9)

    Viral Prep

    #44362-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-hSyn-DIO-hM4D(Gi)-mCherry (#44362). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-hM4D(Gi)-mCherry plasmid DNA. hSyn-driven, Cre-dependent, hM4D(Gi) receptor with an mCherry reporter for CNO-induced neuronal inhibition. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Article

    Krashes et al J Clin Invest. 2011 Apr;121(4):1424-8. d

    Promoter

    Syn

    Tags

    mCherry (Cre-dependent)

    Available Since

    Sept. 20, 2018

    Availability

    Academic Institutions and Nonprofits only

14. AAV pCAG-FLEX-EGFP-WPRE (AAV9)

    Viral Prep

    #51502-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from AAV pCAG-FLEX-EGFP-WPRE (#51502). In addition to the viral particles, you will also receive purified AAV pCAG-FLEX-EGFP-WPRE plasmid DNA. CAG-driven, Cre dependent EGFP expression control. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Hongkui Zeng

    Article

    Oh et al Nature. 2014 Apr 10;508(7495):207-14. do

    Promoter

    CAG

    Tags

    EGFP (Cre-dependent)

    Available Since

    March 8, 2018

    Availability

    Academic Institutions and Nonprofits only

15. pAAV-CaMKIIa-hChR2(H134R)-EYFP (AAV9)

    Viral Prep

    #26969-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-CaMKIIa-hChR2(H134R)-EYFP (#26969). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hChR2(H134R)-EYFP plasmid DNA. CaMKIIa-driven, humanized channelrhodopsin H134R mutant fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Article

    Lee et al Nature. 2010 Jun 10. 465(7299):788-92.

    Promoter

    CaMKII

    Tags

    EYFP

    Available Since

    March 7, 2018

    Availability

    Academic Institutions and Nonprofits only

16. pAAV-hDlx-Flex-GFP-Fishell_6 (AAV9)

    Viral Prep

    #83895-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-hDlx-Flex-GFP-Fishell_6 (#83895). In addition to the viral particles, you will also receive purified pAAV-hDlx-Flex-GFP-Fishell_6 plasmid DNA. hDlx-driven, Cre-dependent expression of GFP. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Gordon Fishell

    Article

    Dimidschstein et al Nat Neurosci. 2016 Oct 31. doi: 10.1038/

    Promoter

    hDlx

    Tags

    GFP (Cre-dependent)

    Available Since

    Nov. 2, 2020

    Availability

    Academic Institutions and Nonprofits only

17. pGP-AAV-syn-jGCaMP8m-WPRE (AAV9)

    Viral Prep

    #162375-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pGP-AAV-syn-jGCaMP8m-WPRE (#162375). In addition to the viral particles, you will also receive purified pGP-AAV-syn-jGCaMP8m-WPRE plasmid DNA. Syn-driven expression of calcium sensor GCaMP8m (faster, more sensitive). These AAV preparations are suitable purity for injection into animals.

    Depositor

    GENIE Project

    Article

    Zhang et al Janelia Research Campus, Online Resource

    Promoter

    Syn

    Available Since

    June 22, 2021

    Availability

    Academic Institutions and Nonprofits only

18. pAAV-CAG-tdTomato (codon diversified) (AAV9)

    Viral Prep

    #59462-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-CAG-tdTomato (codon diversified) (#59462). In addition to the viral particles, you will also receive purified pAAV-CAG-tdTomato (codon diversified) plasmid DNA. CAG-driven tdTomato expression control. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Edward Boyden

    Promoter

    CAG

    Tags

    tdTomato (codon diversified)

    Available Since

    Jan. 26, 2021

    Availability

    Academic Institutions and Nonprofits only

19. pAAV-hSyn-DIO-hM3D(Gq)-mCherry (AAV9)

    Viral Prep

    #44361-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-hSyn-DIO-hM3D(Gq)-mCherry (#44361). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-hM3D(Gq)-mCherry plasmid DNA. Syn-driven, Cre-dependent, hM3D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Article

    Krashes et al J Clin Invest. 2011 Apr;121(4):1424-8. d

    Promoter

    Syn

    Tags

    mCherry (Cre-dependent)

    Available Since

    Sept. 20, 2018

    Availability

    Academic Institutions and Nonprofits only

20. pAAV-hSynapsin1-FLEx-axon-GCaMP6s (AAV9)

    Viral Prep

    #112010-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-hSynapsin1-FLEx-axon-GCaMP6s (#112010). In addition to the viral particles, you will also receive purified pAAV-hSynapsin1-FLEx-axon-GCaMP6s plasmid DNA. Synapsin-driven, cre-dependent axon-targeted GCaMP6s calcium sensor. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Lin Tian

    Article

    Broussard et al Nat Neurosci. 2018 Sep;21(9):1272-1280.

    Promoter

    Syn

    Available Since

    April 2, 2019

    Availability

    Academic Institutions and Nonprofits only